Saturday 17 October 2026 Export AMPH’s income statement to Excel — free account

Amphastar Pharmaceuticals, Inc.

AMPH Healthcare Drug Manufacturers Specialty & Generic

Amphastar Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.9 million, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 5.44%, EPS grew 4.55%, free cash flow grew 87.6% and total debt was flat, each against the same quarter a year earlier.

25.87 0.55 −2.08%

Follow AMPH

Alert me

Market cap: $1.1B
P/E: 14.9×
Fwd P/E: 14.7×
Dividend yield: —
F-score: 6/9
Altman Z: 2.54
Beneish M: −2.57
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	11.29	12.75	11.46	11.60
P/S ratio Full definition →		1.71	1.74	1.23	1.21
P/FCF ratio Full definition →		11.17	10.53	6.69	5.85
P/Operating CF Full definition →		23.55	38.09	18.56	17.16
P/B ratio Full definition →		1.59	1.59	1.15	1.15
Price to Tangible BV Full definition →		6.06	5.62	4.15	7.32
EV/Sales Full definition →		2.17	2.19	1.67	1.64
EV/EBITDA Full definition →		7.51	7.87	6.79	6.87
EV/Operating CF Full definition →		10.31	10.10	7.14	6.50
EV/FCF Full definition →		14.16	13.27	9.07	7.98
Quick Ratio Full definition →		2.08	2.82	2.75	1.67
Current Ratio Full definition →		3.12	4.02	3.85	2.40
Net Debt/EBITDA Full definition →		8.20	6.40	11.03	5.82
Debt/Assets Full definition →		36.58%	37.46%	37.10%	35.10%
Debt/Equity Full definition →		0.78	0.77	0.79	0.80
Asset Turnover Full definition →		0.45	0.45	0.44	0.43
Operating CF/Net income Full definition →		3.03	1.35	7.45	1.69
Capex/Depreciation Full definition →		(0.36)	(0.54)	(0.63)	(0.57)
Interest Coverage Full definition →		4.03	5.37	2.08	5.97
Research and Development Expense of Revenue Full definition →		11.65%	12.73%	15.62%	12.05%
Selling, General and Administrative Expense of Revenue Full definition →		26.57%	14.61%	17.50%	17.17%
Intangible Assets out of Total Assets Full definition →		0.34	0.35	0.34	0.37
Share Based Compensation of Revenue Full definition →		3.28%	3.39%	5.42%	3.86%
Graham Net Nets Full definition →		(0.20)	(0.16)	(0.27)	(0.39)
Graham Number Full definition →		29.79	28.24	25.62	26.25
Earnings Yield Full definition →		8.86%	7.84%	8.73%	8.62%
Free Cash Flow Yield Full definition →		8.95%	9.49%	14.96%	17.09%
Revenue per Share Full definition →		4.13	3.92	3.78	4.21
Operating CF per Share Full definition →		1.13	0.70	1.06	1.18
Capex per Share Full definition →		(0.12)	(0.18)	(0.21)	(0.20)
Free Cash Flow per Share Full definition →		1.02	0.53	0.85	0.98
Cash per Share Full definition →		6.00	6.10	6.50	6.70
Shareholders Equity per Share Full definition →		16.71	16.88	17.06	17.60
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		16.71	16.88	17.06	17.60
Free Cash Flow Full definition →		47.24	24.59	38.33	42.73
Working Capital Full definition →		434.24	477.86	469.21	367.75
Capital Expenditures Full definition →		(5.35)	(8.27)	(9.51)	(8.59)
Net Current Asset Value Full definition →		(250.01)	(204.48)	(241.09)	(344.66)
EV/EBIT Full definition →		10.47	11.23	10.32	10.50
Capex to Sales Full definition →		0.03	0.05	0.06	0.05
Price to Operating Income Full definition →		8.26	8.92	7.61	7.71
Other line items
Average Receivables Full definition →		146.93	149.38	151.42	141.04
Average Payables Full definition →		172.06	152.70	164.31	208.96
Average Inventory Full definition →		158.12	165.32	177.84	185.82
Average Assets Full definition →		1,605.70	1,603.38	1,637.22	1,679.55
Average Common Equity Full definition →		752.21	760.55	762.34	762.82

Show all line items

Columns are period end dates

Stockrow Weekly